Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 74, Issue 10, 1995, Pages 803-808

  Wang, Mingde ^a   Hammarbäck, Stefan ^a   Lindhe, Bengt‐Åke ^b   Bäckström, Torbjörn ^a,b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

mood changes; placebo; premenstrual syndrome; spironolactone

Indexed keywords

PLACEBO; SPIRONOLACTONE; STEROID RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MENSTRUATION; MOOD; ORAL DRUG ADMINISTRATION; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; TABLET;

ADULT; ALDOSTERONE ANTAGONISTS; CROSS-OVER STUDIES; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PLACEBOS; PREMENSTRUAL SYNDROME; SPIRONOLACTONE;

EID: 0029593534     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016349509021201     Document Type: Article

References (19)

1. Neuroendocrinology of premenstrual syndrome
2. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen‐progesterone replacement therapy
3. Neuroactive steroids
4. Interaction of convulsive ligands with benzodiazepine receptors
5. Inhibition of anesthetics and sedative actions by spironolactone
6. Spironolactone actions independent of mineralocorticoid blockade
7. Treatment of premenstrual syndrome by spironolactone
8. Premenstrual tension: a placebo‐controlled efficacy study with spironolactone and medroxyprogesterone acetate
9. Premenstrual syndrome and spironolactone
10. Mood, sexuality, hormones and the menstrual cycle. I. Changes in mood and physical state: description of subjects and methods
11. Diagnosis of premenstrual syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis
12. Lateral luteal phase dysphoric disorder
13. Induced anovulation as treatment of premenstrual syndrome: a double‐blind crossover study with GnRH‐agonist versus placebo
14. Spironolactone for premenstrual syndrome
15. A double‐blind placebo‐controlled evaluation of spironolactone in the premenstrual syndrome
16. Helping women with premenstrual syndrome
17. Evidence for altered transcapillary fluid balance in women with the premenstrual syndrome
18. Effect of spironolactone on premenstrual syndrome
19. Hormonal and biochemical profiles of premenstrual syndrome